Literature DB >> 3266729

High frequency of antimicrobial resistance in human fecal flora.

S B Levy1, B Marshall, S Schluederberg, D Rowse, J Davis.   

Abstract

The frequency of resistance to seven different antimicrobial agents was examined in the aerobic gram-negative gut flora of over 600 individuals from hospitals, from laboratories where antibiotics were used, and from urban and rural communities. In a majority (62.5%) of fecal samples from people without a recent history of taking antibiotics, 10% or more of the total organisms were resistant to at least one of the antibiotics. In about 40% of the samples, resistance to more than one drug was present at this level. More than one-third of the samples contained resistant organisms comprising 50% or more of the total flora examined. Organisms with coresistance to multiple drugs were found frequently. Individuals taking antibiotics produced more samples with a higher proportion (greater than 50%) of resistant bacteria, and these samples also had a significantly greater number of different resistance determinants. This extensive study revealed a high prevalence of resistant bacteria in the gut flora of ambulatory and hospitalized individuals whether or not they were taking antibiotics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266729      PMCID: PMC176022          DOI: 10.1128/AAC.32.12.1801

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Replica plating and indirect selection of bacterial mutants.

Authors:  J LEDERBERG; E M LEDERBERG
Journal:  J Bacteriol       Date:  1952-03       Impact factor: 3.490

2.  Transferable drug resistance in enterobacteria isolated from urban infants.

Authors:  E C Moorhouse
Journal:  Br Med J       Date:  1969-05-17

3.  Drug resistance and R factors in the bowel bacteria of London patients before and after admission to hospital.

Authors:  N Datta
Journal:  Br Med J       Date:  1969-05-17

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

5.  Observations on infective drug resistance in Britain.

Authors:  H W Smith; S Halls
Journal:  Br Med J       Date:  1966-01-29

6.  Microbiological changes in the human fecal flora following the administration of tetracyclines and chloramphenicol.

Authors:  D Sompolinsky; V Yaron; W J Alkan
Journal:  Am J Proctol       Date:  1967-12

7.  Incidence of antibiotic resistance and transmissible R factors in the gram-negative bowel flora of hospital patients on admission.

Authors:  H Sogaard
Journal:  Scand J Infect Dis       Date:  1975

8.  Effect of stay in hospital and oral chemotherapy on the antibiotic sensitivity of bowel coliforms.

Authors:  E J Shaw; N Datta; G Jones; F M Marr; W J Froud
Journal:  J Hyg (Lond)       Date:  1973-09

9.  Changing faecal population of Escherichia coli in hospital medical patients.

Authors:  E M Cooke; S Ewins; R A Shooter
Journal:  Br Med J       Date:  1969-12-06

10.  Survival of Escherichia coli host-vector systems in the mammalian intestine.

Authors:  S B Levy; B Marshall; D Rowse-Eagle; A Onderdonk
Journal:  Science       Date:  1980-07-18       Impact factor: 47.728

View more
  45 in total

1.  P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin.

Authors:  Ann-Mari Tarkkanen; Tuula Heinonen; Rain Jõgi; Silja Mentula; Michel E van der Rest; Curtis J Donskey; Tuomas Kemppainen; Konstantin Gurbanov; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

2.  Antimicrobial resistance of fecal aerobic gram-negative bacilli in different age groups in a community.

Authors:  T Leistevuo; J Leistevuo; M Osterblad; T Arvola; P Toivonen; T Klaukka; A Lehtonen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Phylogeny of mercury resistance (mer) operons of gram-negative bacteria isolated from the fecal flora of primates.

Authors:  C A Liebert; J Wireman; T Smith; A O Summers
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

Review 4.  Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes.

Authors:  Eileen Broaders; Cormac G M Gahan; Julian R Marchesi
Journal:  Gut Microbes       Date:  2013-04-12

Review 5.  Antibiotics and the gut microbiota.

Authors:  Sheetal R Modi; James J Collins; David A Relman
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

6.  Horizontal transfer of a multi-drug resistance plasmid between coliform bacteria of human and bovine origin in a farm environment.

Authors:  H Oppegaard; T M Steinum; Y Wasteson
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

7.  Trimethoprim resistance in South African isolates of aerobic gram-negative faecal flora.

Authors:  P V Adrian; H J Koornhof; B A Wylie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

8.  Indications of in vivo transfer of an epidemic R plasmid from Salmonella enteritidis to Escherichia coli of the normal human gut flora.

Authors:  E Balis; A C Vatopoulos; M Kanelopoulou; E Mainas; G Hatzoudis; V Kontogianni; H Malamou-Lada; S Kitsou-Kiriakopoulou; V Kalapothaki
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela.

Authors:  H J van de Mortel; E J Jansen; G J Dinant; N London; E Palacios Prü; E E Stobberingh
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

10.  Antimicrobial resistance in human oral and intestinal anaerobic microfloras.

Authors:  C A Stark; C Edlund; S Sjöstedt; G Kristensen; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.